Antibody formation to factor VIII can also be a major concern for patients receiving therapy against bleeding; the incidence of these inhibitors is dependent of various factors, including the factor VIII product itself.
A formación de anticorpos contra o factor VIII pode ser tamén unha preocupación importante en pacientes que reciben terapia contra as hemorraxias; a incidencia destes inhibidores depende de varias proteínas factores, como o propio factor VIII.